Association of a novel BRCA2 mutation with prostate cancer risk further supports germline genetic testing.
Saved in:
| Title: | Association of a novel BRCA2 mutation with prostate cancer risk further supports germline genetic testing. |
|---|---|
| Authors: | Foley GR; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, 7000, Australia., Marthick JR; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, 7000, Australia., Ostrander EA; Cancer Genetics and Comparative Genomics Branch, National Human Genome Research Institute, NIH, Bethesda, MD 20892, USA., Stanford JL; Fred Hutchinson Cancer Center, 1100 Fairview Ave. N., M4-B874, Seattle, WA 98109-1024, USA., Dickinson JL; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, 7000, Australia., FitzGerald LM; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, 7000, Australia. Electronic address: liesel.fitzgerald@utas.edu.au. |
| Source: | European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2023 Feb; Vol. 180, pp. 155-157. Date of Electronic Publication: 2022 Dec 10. |
| Publication Type: | Letter; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1879-0852 |
|---|---|
| DOI: | 10.1016/j.ejca.2022.11.034 |
